Search research articles
Contact Us
Filters
Showing results (1231-1240 of 1,257) with videos related to
Page
of 126
Sort By:
International Journal of Environmental Research and Public Health
|
December 26, 2015
Glyceollin I Reverses Epithelial to Mesenchymal Transition in Letrozole Resistant Breast Cancer through ZEB1
Patrick P Carriere, Shawn D Llopis, Anna C Naiki, et al.
The Lancet. Diabetes & Endocrinology
|
May 11, 2026
A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trial
Sophia Zoungas, David D'Alessio, Imre Pavo, et al.
JAMA
|
February 15, 2007
Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial
Gregg W Stone, Michel E Bertrand, Jeffrey W Moses, et al.
JAMA
|
November 15, 2020
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial
Stephen J Nicholls, A Michael Lincoff, Michelle Garcia, et al.
Journal of the American College of Cardiology
|
September 4, 2024
ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction: Insights From the AEGIS-II Trial
C Michael Gibson, Gerald Chi, Danielle Duffy, et al.
The New England Journal of Medicine
|
June 16, 2023
Cardiovascular Safety of Testosterone-Replacement Therapy
A Michael Lincoff, Shalender Bhasin, Panagiotis Flevaris, et al.
Environment International
|
November 10, 2019
Statement on advancing the assessment of chemical mixtures and their risks for human health and the environment
Elina Drakvik, Rolf Altenburger, Yasunobu Aoki, et al.
The New England Journal of Medicine
|
December 17, 2025
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes
Stephen J Nicholls, Imre Pavo, Deepak L Bhatt, et al.
Shock (Augusta, Ga.)
|
December 11, 2012
Tranexamic acid and trauma: current status and knowledge gaps with recommended research priorities
Anthony E Pusateri, Richard B Weiskopf, Vikhyat Bebarta, et al.
The New England Journal of Medicine
|
May 18, 2017
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
A Michael Lincoff, Stephen J Nicholls, Jeffrey S Riesmeyer, et al.
Page
of 126
Search research articles
Search
Showing results (1231-1240 of 1,257) with videos related to
Sort By:
Page
of 126
International Journal of Environmental Research and Public Health
|
December 26, 2015
Glyceollin I Reverses Epithelial to Mesenchymal Transition in Letrozole Resistant Breast Cancer through ZEB1
Patrick P Carriere, Shawn D Llopis, Anna C Naiki, et al.
The Lancet. Diabetes & Endocrinology
|
May 11, 2026
A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trial
Sophia Zoungas, David D'Alessio, Imre Pavo, et al.
JAMA
|
February 15, 2007
Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial
Gregg W Stone, Michel E Bertrand, Jeffrey W Moses, et al.
JAMA
|
November 15, 2020
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial
Stephen J Nicholls, A Michael Lincoff, Michelle Garcia, et al.
Journal of the American College of Cardiology
|
September 4, 2024
ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction: Insights From the AEGIS-II Trial
C Michael Gibson, Gerald Chi, Danielle Duffy, et al.
The New England Journal of Medicine
|
June 16, 2023
Cardiovascular Safety of Testosterone-Replacement Therapy
A Michael Lincoff, Shalender Bhasin, Panagiotis Flevaris, et al.
Environment International
|
November 10, 2019
Statement on advancing the assessment of chemical mixtures and their risks for human health and the environment
Elina Drakvik, Rolf Altenburger, Yasunobu Aoki, et al.
The New England Journal of Medicine
|
December 17, 2025
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes
Stephen J Nicholls, Imre Pavo, Deepak L Bhatt, et al.
Shock (Augusta, Ga.)
|
December 11, 2012
Tranexamic acid and trauma: current status and knowledge gaps with recommended research priorities
Anthony E Pusateri, Richard B Weiskopf, Vikhyat Bebarta, et al.
The New England Journal of Medicine
|
May 18, 2017
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
A Michael Lincoff, Stephen J Nicholls, Jeffrey S Riesmeyer, et al.
Page
of 126